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The characteristics of patients with CVD have changed: whereas smoking prevalence declines, obesity and metabolic syndrome
are on the rise. Unfortunately, the traditional low-fat diet for the prevention of cardiovascular disease (CVD) still seems to
be the “mainstream knowledge” despite contradicting evidence. But lowering LDL-cholesterol by the wrong diet even may be
counterproductive, if sd-LDL is raised and HDL is lowered. New insights into the pathophysiology of insulin resistance and its
inﬂuence on the eﬀects of dietary changes have led to a better approach: (1) the higher a patient’s insulin resistance, the more
important is the glycemic load of the diet. (2) Fat quality is much more important than fat quantity. (3) The best principle for a
reduced calorie intake is not fat counting, but a high volume diet with low energy density, which means ﬁbre rich vegetables and
fruits. (4) And ﬁnally, satiation and palatability of a diet is very important: there is no success without the patient’s compliance.
Thus, the best approach to the dietary prevention of CVD is a Mediterranean style low-carb diet represented in the LOGI pyramid.
Dietary guidelines for the prevention of CVD should to be revised accordingly.
1.Introduction
In nutritional medicine evidence is more diﬃcult to obtain
than in cardiovascular drug studies, where RCTs with hard
end-points are the gold standard. Conclusions in nutritional
medicine arefrequentlydrawnfromepidemiological studies,
which are subject to many possible confounders. There are
very few randomised studies with coronary heart disease
(CHD) or total mortality as the endpoint, and those studies
(like some trials in mental hospitals in the 1970s) do not
meet our current ethical and scientiﬁc standards. Unlike
laboratory animals, human beings cannot be fed over a long
time; thus most nutritional intervention studies are short to
medium term and focus on surrogate parameters.
Controlled dietary intervention studies nevertheless can
give important insights into the possibilities of dietary chan-
ges. If there are known pathophysiological mechanisms, a
dose-response relation in the intervention, biological plau-
sibility, and consistency with epidemiological studies, then
eﬀects of dietary changes can be considered as plausible.
One big misconception should be avoided: hardly any
food is “bad” or “good” for health per se.W h e np e o p l ee a t
less of one kind of food, they will likely exchange it for a
diﬀerent one, because they usually eat “ad libitum”, meaning
until they are satisﬁed. So it is always about exchanging one
food item for another one—and the main question is, which
changes are best for our patient’s health.
The intention of this paper is to stimulate discussions
about whether the current guidelines should be adapted to
the latest evidence and to give an insight into the ongoing
debate, which diets are best for the prevention of cardiovas-
cular disease.
2.DietandHeartDisease
Traditionally, low-cholesterol (LC) and low-fat-high-carb
(LFHC) diets have been recommended with the intention to
reduce cardiovascular disease (CVD) and obesity risk. The
evidence behind this dietary strategy is questionable.
Recent data from NHANES show trends in dietary ma-
cronutrient composition, total energy intake, and the preva-
lence of overweight and obesity from 1971 to 2006. While
relative percentage of fat in the diet decreased signiﬁcantly
from 36,6% to 33,7% and the percentage of carbohydrates2 Cholesterol
increased from 44,0 to 48,7%, which complied with the oﬃ-
cial LFHC recommendations, total energy intake increased,
too, and US people became fatter and fatter [2]. This casts
doubt on whether the recommendation to “eat less fat” has
had any beneﬁcial eﬀect on a population level.
A recent “systematic review of the evidence supporting a
causal link between dietary factors and coronary heart dis-
ease” came to the conclusion that strong evidence support-
ed a protective associations between vegetables, nuts, mo-
nounsaturated fatty acids and a “mediterranean” style, high-
quality diet and coronary heart disease (CHD), and harmful
associationswiththeintakeoftransfattyacidsandfoodswith
a high glycemic index or load. Neither for saturated fat nor
for eggs, there was suﬃcient evidence for any harm [3].
For more than ten years, leading experts in the ﬁeld
have been advocating a paradigm shift in dietary recommen-
dations for the prevention of heart disease [1, 4, 5]. They
are opposed by strong lobbyism of the food industry, who
is against any regulations, for example, of sugar-sweetened
beverages or labelling of processed food with high energy
density.
In routine, daily patient care, doctors still take remark-
ably little notice of this controversy and of the new, high-
quality evidence about the eﬀects of dietary changes, which
has been accumulated within the last decade.
3. ChangingPatients, Changing
Recommendations?
The “typical patient” with CHD may have changed in the
last decades. Smoking prevalence has declined whereas over-
weight and obesity, Metabolic Syndrome (MetS), and Type 2
diabetes mellitus (T2DM) are on the rise.
About two-thirds of patients with coronary heart disease
have either T2DM or an impaired glucose tolerance (IGT)
[6]. The increasing prevalenceof the MetS and the increasing
incidence of T2DM in industrialized countries may lead
in a long-term perspective to a greater lifetime burden of
cardiovascular disease.
Recommendations must meet the needs of the target
population and must thus be adapted to their metabolic
proﬁle. Within the last 10–15 years, high-quality evidence
has been accumulated through dietary intervention studies
in dyslipidemic, prediabetic, and/or diabetic subjects, in lean
and in obese subjects with and without insulin resistance,
whichhaveclariﬁedtheinﬂuenceofdietarychangesonlipids
and apolipoproteins, weight reduction, glycaemia, and insu-
linemia.Itisimportanttoincorporatethisnewevidenceinto
dietary guidelines for cardiovascular prevention.
4.Who Isthe Target Population?
The target population is individuals with
(a) the metabolic syndrome (MS) and insulin resistance,
(b) hypertension,
(c) hypercholesterolemia,
(d) overweight and obesity,
and very often combinations of the four.
Patients with MS have a twofold increased risk for CVD
already before the manifestation of T2DM and are typi-
cally characterized by the (pre)diabetic dyslipoproteinemia
(small-dense LDL, high ApoB, low HDL, low Apo-A1, high
triglycerides) and fasting as well as postprandial hyperinsu-
linemia, in many cases by arterial hypertension and signs of
premature atherosclerosis (raised IMT), too.
5. What Arethe Objectivesof Dietary
Changes inTarget Population?
Themainobjectiveistolowertheindividuals’overallcardio-
vascular disease (CVD) risk. Dietary recommendations for
this target population should therefore
(i) improve dyslipoproteinemia (lower TG, increase
HDL, lower TC:HDL ratio, lower small dense LDL,
and ApoB),
(ii) lower blood pressure,
(iii) lower postprandial glycaemia and insulinemia,
(iv) facilitate weight control,
(v) ensure adequate intake of essential nutrients,
(vi) ensure eating pleasure and thus compliance,
(vii) ﬁnally reduce the risk for CVD morbidity and
mortality.
6.DietaryChanges to Improve
Dyslipoproteinemia
Traditionally, low-cholesterol (LC) and low-fat-high-carb
(LFHC) diets have been recommended to improve dyslipo-
proteinemia. Yet the value of reducing dietary cholesterol has
never been established according to EBM criteria.
The individual response to dietary cholesterol has been
extensively studied [7]: whereas about 25% experience a
makeable increase of both circulating LDL and HDL cho-
lesterol (hyperresponders), about 75% of the population
experiences only a mild increase or no alterations in plas-
m ac h o l e s t e r o lc o n c e n t r a t i o n sw h e nc h a l l e n g e dw i t hh i g h
amounts of dietary cholesterol (normal responders and hy-
poresponders). Egg intake promotes the formation of large
LDL and HDL subclasses, which are less atherogenic [8]. It
may even be triggered by the question, whether an individual
was breast-fed as an infant, which seems to downregulate
cholesterol synthesis.
Although it had been shown very early in the 1950s
that dietary cholesterol and eggs are not relevant for serum
c h o l e s t e r o ll ev el s[ 9–11],it took many yearsto exculpate eggs
from being a cause of myocardial infarction (MI) and stroke
of CVD [12, 13].
Most cohort studies, among them a recent analysis of
NHANES,didnotﬁndanassociationbetweeneggconsump-
tion and CVD [14]. Contrasting to that, an analysis from the
Physicians’ Health Study found an association between egg
consumption and total mortality (but not MI and stroke),
which was pronounced in diabetic physicians, the reason for
w h i c hi su n c l e a r[ 15]. Cohort studies are subject to possibleCholesterol 3
Figure 1: Cover of Willet’s 2003 review article [1], with kind permission of Nature Publishing Group.
confounders.Itisnotknowniftherewerelifestylediﬀerences
between physicians eating less than one egg per week and
thoseeating morethansixeggsperweek.Interestingly,inthe
context of a carbohydrate-restricted diet, consumption of
three eggs per day compared with no eggs favourably in-
ﬂuenced the lipoprotein proﬁle in overweight/obese male
subjects [16, 17]. So the eﬀect of egg consumption in indi-
viduals with the metabolic syndrome and/or diabetes may be
modiﬁed by the carbohydrate content of the diet. In con-
clusion, there is no suﬃcient evidence to recommend a
general restriction of egg consumption, which is still part of
many dietary guidelines [12].
Further, the much advocated LFHC diets never had
been proven to reduce CVD risk, although this still is the
assumption of many physicians and nutritionists [18]. As
WalterWillettput itin hisremarkable2003review(Figure 1)
in the Scientiﬁc American, “The dietary guide we introduced
a decade ago has lead people astray. Some fats are healthy for
the heart, and many carbohydrates clearly are not.” [1].
Besides, the last statement considering carbohydrates
made lobbyists of the food industry to accuse Willett of a
“political statement”. This ﬁnally led to his exclusion from
the 2005 committee, which revised the “Dietary Guidelines
for Americans”. Food politics always had a great inﬂuence on
dietary recommendations.
It is noteworthy that before LFHC diets became popular,
carbohydrates had been blamed for decades as the main
culprit for diabetes, obesity, and coronary heart disease
(CHD) [19].
High-quality evidence from meta-analyses of controlled
nutrition intervention studies [20, 21] has now contradicted
the traditional assumption that LFHC diets are the best
recommendation to improve blood lipids. It has been
clearly demonstrated that fat quality is the most important
determinant of changes in blood lipids, not total fat content
nor the relative percentage of fat in a diet [20].
(i) Exchanging saturated fats (less) for carbohydrates
(more) will moderately lower LDL cholesterol but
shift LDL subclasses to an unfavourable pattern B
(small-dense LDL and higher ApoB). It will lower
HDL stronger than LDL and raise triglycerides
(TG), thus possibly deteriorating CVD risk, instead
of improving it [22–24]. Exchanging carbohydrates
(less) for saturated fats (more) induces only a small
rise in TC:HDL ratio but will raise LDL size to a
more favourable pattern [20, 25]. Of the four major
sources of saturated fat (Lauric, myristic, palmitic,
and stearic acid) only palmitic acid raises TC:HDL
ratio, myristic acid is neutral, and lauric acid and
stearic acid lower TC:HDL ratio and may even be
beneﬁcial [20, 26].
(ii) Exchanging carbohydrates (less) for mono- or
polyunsaturated fats (more) will strongly reduce
TC:HDL ratio, lower TG, and favourably inﬂuence
CVD risk [27].
(iii) Exchanging saturated fats for mono- or polyunsatu-
rated fats will improve TC:HDL ratio, too.
(iv) Only transfatty acids signiﬁcantly deteriorate TC:
HDL ratio if they substitute carbohydrates [20].
Low-fat-high-carb (LFHC) diets are apparently con-
traproductive and induce unfavourable lipid changes in
overweight and obese individuals, who are insulin resistant.
The metabolic proﬁle is important for the patient’s response
to dietary changes: the more insulin resistant, the worse they
do with a low-fat-high-carb diet. To the contrary, diets high
in monounsaturated fatty acids and lower in carbohydrate
content perform much better in T2DM according to a meta-
analysis [27–30].
A randomised, controlled, high-quality nutrition inter-
vention study by the group of Ronald Krauss from San
Francisco clearly demonstrated the beneﬁt of a low-carb-
high-fat diet (LCHF) on blood lipids in overweight men: it
compared a “prudent” LFHC diet (54% Carb, 16% Protein,
30% Fat) with a low-fat-high-protein-moderate-carb diet
(39% Carb, 29% Protein, 31% Fat), an LCHF diet with
predominantly monounsaturated fatty acids (26% Carb,
29%Protein,46%Fat),andanLCHFdiethigherinsaturated
fat (26% Carb, 29% Protein, 45% Fat). After a 1-week-run-
in-phase, where all men ate a control-diet with 54% Carbs,
it randomised the participants on the respective four diets
f o r3w e e k sw i t hs t a b l ew e i g h t( i s o c a l o r i c ) .A f t e rt h i sp e r i o d
the most favourable changes were seen in the LCHF diet with
predominantly monounsaturated fatty acids: TC:HDL ratio4 Cholesterol
was reduced by 13% in the LCHF group, whereas the LFHC
group did not show an improvement. Lowering of ApoB was
much better in the LCHF groups than in the LFHC group
[31].
In the following weight-loss period all participants lost
weight by calorie restriction on their respective diets. After 9
more weeks, there were improvements in all groups, which
clearly separated the eﬀects of diet alone and diet in combi-
nation with weight-loss.
This is an important aspect in the discussion, because
long-term weight loss, as desirable as it may be, will remain
an illusion for many individuals with weight problems.
Therefore the more important is the fact that favourable
changes in blood lipids are achievable without weight loss,i f
insulin resistant individuals follow an LCHF diet [32].
Thus, isocaloric exchanges of mono/polyunsaturated
fatty acids (more) for carbohydrates (less) and/or protein
(more)forcarbohydrates(less)bothimproveTC:HDLratio
and LDL:HDL ratio and lower TG levels [20, 31]. The
eﬀect of LCHF diets is especially strong in overweight, obese,
and/or insulin-resistant individuals.
7. Sidestep:Transfatty Acids
A widely neglected, but still very important aspect, is the
problem of transfatty acids (TFAs) in fast food, bakery fats,
a n de s p e c i a l l yi ns n a c kf o o d s[ 33, 34]. Transfatty acids in
human nutrition mainly stem from partially hydrogenated
vegetable oils. They raise LDL cholesterol, lower HDL-
cholesterol, promote systemic inﬂammation, and deteriorate
insulin sensitivity [35–37]. Unlike Denmark (since 2002),
New York (2007), Switzerland (2008), and recently Califor-
nia, there is no ban on the use of TFA nor any obligation to
declare its content in foods in Germany or in the European
Union. Considering the importance of TFA with strong
evidence for a causal link with CVD, there is an urgent need
for political action towards a Europeanwide ban.
8. Effects of Different Diets on Hypertension
Reducing the dietary sodium content [38, 39] and raising
the intake of potassium- and calcium-rich foods [40, 41]
(e.g., fruits, vegetables, or dairy products) have been shown
to lower blood pressure. The exchange of carbohydrates
for either more protein or more unsaturated fatty acids
lowered blood pressure and improved lipid proﬁles in the
OmniHEART-Trial [42].
The DASH Diet is in fact a Mediterranean-style diet with
10 portions of fruits and vegetables per day, more dairy
products, low sodium content, and less sugar and starch. Its
glycemic load (GL) is reduced in comparison to the average
American diet by preferring whole grain products instead of
reﬁned carbohydrates.
9. Effects of DifferentDiets onthe Risk
for T2DM
For quite a while now, the same low-fat-high-carb (LFHC)
diet that was proposed for CVD prevention has been recom-
mended in oﬃcial guidelines to individuals with overweight,
MetS, and T2DM. The main focus was lowering of TC and
LDL-C, irrespective of the also known eﬀects of such a high
glycaemic load on HDL-C and glucose metabolism. A rise
in glucose was lowered by medication (oral antidiabetics or
insulin). Lately, the negative eﬀects of such an approach,
which favours hyperinsulinemia and ß-cell-exhaustion, have
been demonstrated [43–45]. In the EPIC study and in
a recently published meta-analysis of prospective studies,
carbohydrate quantity and quality (GI/GL) were associated
with a higher risk for T2DM [43, 46, 47].
Gerald Reaven, the “father” of the concept of insulin
resistance and the Metabolic Syndrome, concluded in his
2005 review on dietary approaches in insulin resistance:
“There is considerable evidence that isocaloric diets, low in
fat and enriched in CHO, will accentuate the manifestations
of the IRS. The more insulin resistant an individual, the
greater is the amount of insulin that must be secreted in
response to a CHO-enriched diet in order to maintain glucose
homeostasis. Thus, the inevitable, and consistently replicated,
eﬀect of replacing SF with CHO in insulin-resistant individuals
is to increase daylong concentration of glucose or insulin, or
both. In addition, this dietary approach has consistently been
shown to stimulate hepatic VLDL-TG synthesis and secretion,
leading to an increase in concentration of TG-rich lipoproteins,
both in the fasting and postprandial states. The increase in
the ambient TG-rich lipoproteins seen following low-fat/high-
CHO diets has previously been shown to be associated with
a decrease in HDL-C concentration, and it appears that such
diets will change the LDL subclass pattern to B in 36 of 87
individuals(41%)whohadeitherpatternAoranintermediate
pattern at the outset.” [48].
Interestingly, in the preinsulin era, the dietary approach
to treat T2DM was quite diﬀerent and is experiencing its
renaissance in the last years [19].
A recent meta-analysis of 37 prospective observational
studies concluded that diets with a high GI or GL indepen-
dently increased the risk of type 2 diabetes, heart disease,
gallbladder disease, breast cancer, and all diseases combined
[49].
The pathophysiological basis for the detrimental eﬀects
of carbohydrates in susceptible individuals has been clariﬁed
bythelandmarkstudiesofPetersenetal.fromYaleUniversity
[50–52]. They discovered that an impaired mitochondrial
function with a lower rate of conversion of diacyl-glycerol
(DAG) to triglycerides (TGs) due to a genetic predisposition
will lead to intracellular DAG accumulation, which impairs
insulin signalling pathways [53]( Figure 2).
In combination with physical inactivity especially this
causes muscular insulin resistance with reduced glucose up-
take. After a high carbohydrate meal under these conditions,
glucose will be redirected to the liver, where it induces de
novo lipogenesis, fat storage in the liver, and ﬁnally hepatic
insulin resistance with visceral obesity and all its known con-
sequences.Fromthesameamountofingestedcarbohydrates,
lean, but insulin resistant students will have a more than
doubled de novo lipogenesis in liver as their insulin-sensitive
controls. One short bout of physical activity can reverse this
eﬀect, underlining the importance of a lifestyle approachCholesterol 5
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Figure 2: Pathophysiology of muscular insulin resistance: normal (a) and impaired (b) insulin signalling pathway (from [53], reprint with
kind permission of Elsevier Limited).
combining dietary with physical activity recommendations
in insulin resistant subjects [54].
Also, genetic deﬁcits in insulin secretion may play a role
in the development of T2DM [55]. The higher the glycaemic
load of the diet, the more diﬃcult it is for individuals with
this frequent genetic mutation, to achieve glucose home-
ostasis. Besides, muscular activity can reverse the negative
eﬀects of this genetic deﬁciency, too, as has been shown in
the American Diabetes Prevention Study [55].
On the other hand, controlled nutrition intervention
studies have validated the inﬂuence of glycaemic load on
postprandial glycaemia and have shown a beneﬁt of carbo-
hydrate-restricted diets with a higher content of protein and
f a ti np r e d i a b e t i cs u b j e c t sa sw e l la si nd i a b e t i c s[ 56–65].
Considering this, it is not a surprise that the latest pub-
lication from the Kuopio study published in February 2011
showed the GI/GL to be associated with a signiﬁcant increase
in the risk for acute myocardial infarction in overweight
and/or physically inactive men [66].
10.DietaryChanges and WeightLoss
Controlled dietary intervention studies have demonstrated
that low-carb-high-fat (LCHF) diets or low-glycaemic-index
(LOGI) diets in comparison to low-fat-high-carb (LFHC)
diets double the weight loss achieved over 6 months [67–73].
Also Low-Glycemic Load Diets (LOGI) have shown superior
weight loss [74–76]. In insulin-resistant subjects especially,
there is a better weight loss, when carbohydrates and/or
glycaemic index are reduced. The myth that fat content of a
diet is the main culprit for weight gain and obesity has been
contradicted by these studies.
Interestingly, most studies tested calorie-restricted low-
fat diets against ad libitum low-carb diets, and still low-carb
performed better. The explanation is that low-carb but high-
protein and high-fat diets promote better satiety than the
traditional low-fat, low-protein, high-carb diets.
And furthermore, the energy density of a diet, which is
responsible for the initial satiating eﬀect, depends more on
the water and ﬁbre content of a diet than on the relative fat
content. A “high-fat” diet with a relative fat content of 40–
50% en but with plenty of fruits and vegetables can still be
“low-caloric”, because of a low energy density of the com-
bined meal. This common misunderstanding of the term
“high-fat” should be clariﬁed at this point.
As the compliance with all dietary changes tends to
degrade with time, regain of weight is initiated typically after
6–12 months. But still after 12 to 24 months there is a trend
for higher weight loss on LCHF diets [73].
A recent meta-analysis of weight loss diets by the
Cochrane Collaboration leads the authors to the following
conclusions: “Overweight or obese people on low glycaemic
index diets lost more weight than those on high glycaemic index
diets or conventional energy restricted weight loss diets, with
the change in body mass, total fat mass and body mass index
all signiﬁcantly decreasing after the low glycaemic index diet
compared to the comparison diet. It may be easier to adhere
to a low glycaemic index diet than a conventional weight loss
diet, since there is less need to restrict the intake of food as
long as low glycaemic index carbohydrates are predominantly
consumed. In studies comparing ad libitum reduced glycaemic
index or load diets to conventional restricted low fat diets, even
though participants could eat as much as desired on the low
glycaemicindexorloaddiets,theyfaredaswell,orbetter,inthe
outcomes than those on the comparison diet. Hence, lowering6 Cholesterol
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Figure 3: The “LOGI pyramid” according to Dr. Nicolai Worm, revised version 08/2009.
theglycaemicindexoffoodsinthedietappearstobeaneﬀective
method of losing weight, particularly for the obese.” [74].
11. Conclusion and Practical Approach
The aforementioned cited evidence convincingly argues for a
change in dietary recommendations towards the prevention
of CHD. In those patients with preponderance to overweight
and diabetes especially, and in those who are most of the day
physically inactive, reducing carbohydrates (low GL) is ben-
eﬁcial, if carbs are exchanged for good fats and/or protein.
Renowned institutions like the Joslin Diabetes Center
already have revised their nutrition guidelines (Clinical
nutritionguidelineforoverweightandobeseadultswithtype
2 diabetes, prediabetes, or those at high risk for developing
type 2 diabetes).
As any dietary strategy should be evidence-based, eﬀec-
tive, and—in a real-life setting—practical from the patients’
point of view, it has to be palatable, too.
One of most successful approaches into this direction
is the LOGI concept created by David Ludwig, Harvard
University, which was made popular in the German version
by Dr. Nicolai Worm (Figure 3).
LOGI is “mediterranian-style low-carb” and combines
practicability and palatability: it is based on an abundance of
plant-based foods (fruits, low-starch vegetables, and salads),
combinedwith“goodfats”(monounsaturatedandomega-3-
polyunsaturated, olive oil, canola oil, nuts, seeds, ﬁsh), more
protein (low-fat dairy products, legumes, ﬁsh, poultry), and
only small amounts of the classical carbohydrate-rich foods
like pasta, whole-meal-bread, rice, and potatoes.
Breakfast cereals, snacks, sweets, and sugar-sweetened
beveragesshouldbestrictlylimited.Fromthetwobasiclevels
(fruits/vegetables/salads/good fats, and protein sources),
patients can eat ad libitum, which makes compliance very
good with LOGI. There is a wealth of literature about
LOGI with excellent cooking book for patients, containing
easy-to-prepare recipes with calculations for energy den-
sity, carb/fat/protein content, and nutritional values (see
http://www.logi-methode.de/).
12.ProposedPracticalDietary
Recommendations for the Prevention
of CVD
(i) Change fat quality to improve dyslipoproteinemia:
(1) goodfats:olive oil,canola/rapeseedoil,nut oils,
nuts, seeds, and ﬁsh with omega-3-fatty acids,
(2) neutral fats: saturated fats in milk products and
cheese,
(3) bad fats: fat in processed meat, sausages, trans-
fatty acids in bakery products, cookies, sweets,
and so forth.
(ii) Eat plenty high-volume-low-calorie foods: vegeta-
bles, salads, and fruits.
(iii) Reduce total carb intake, prefer low-glycaemic index
foods, and reduce glycaemic load to lower fasting
andpostprandial glucose andinsulin levels(the more
insulinresistant,thestrongerthisrecommendationis
to be followed!):
(1) good carbs: nonstarchy vegetables, salads,
legumes, most fruits, and whole and minimally
processed grains,
(2) if you eat carbs, eat few and prefer whole grain
bread, brown rice, and pasta,
(3) carbs to avoid: low-ﬁbre cereals, sugars, HFCS
(high-fructose-corn-sirup) sweetened softdr-
inks,snacks,pizza,fries,bakedpotatoes,sweets,Cholesterol 7
white and brown bread, and all foods contain-
ing reﬁned starch.
(iv) Eat more protein for better and longer lasting satiety:
(1) good protein sources: ﬁsh, poultry, low-fat
dairy products, and lean-cut meat.
(2) protein sources to avoid: processed red meat
and sausages.
(v) Moderate alcohol consumption:
(1) regular small amounts of alcohol (preferably
wine) can be part of a healthy diet (10–20g per
day),
(2) if individuals prefer to drink small amounts of
wine on a regular basis, it is OK,
(3) excessive drinking is detrimental to health,
(4) nobody should start drinking alcohol for pre-
ventive reasons,
(5) alcohol consumption should always be part of
a culture of healthy good cooking (Mediter-
ranean style).
(vi) Physical activity recommendations: 30 min daily of
moderate physical activity is the minimum amount
necessary for health (and should be part of the nutri-
tion guideline, too).
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